COVID-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England (PHE) showed on Monday.
PHE said that the Pfizer/Biontech COVID-19 vaccine was 96% effective against hospitalisation from the Delta variant after two doses, while Oxford/AstraZeneca’s offered 92% protection against hospitalisation by Delta.
Read the full article.
Very very good news from Public Health England: the vaccine works on the Delta/Indian variant
Pfizer 96% effective against hospitalisation after 2 doses
AstraZeneca 92% effective against hospitalisation after 2 doses
This is a lot better than experts had previously feared
— Alex Wickham (@alexwickham) June 14, 2021